A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

A new study finds that prior herpesvirus infections are linked to a faster age-related increase in blood biomarkers ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

Introduction: Herpes zoster is the reactivation of the varicella zoster virus (VZV), which remained quiescent in the Gasser ...

The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world's population and is generally ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.